Status:
NOT_YET_RECRUITING
Short Term Outcomes After Primary PCI in Diabetic Patients Treated With Insulin Versus Oral Anti-diabetic Drugs
Lead Sponsor:
Assiut University
Conditions:
Diabetes Mellitus
PCI
Eligibility:
All Genders
Brief Summary
• This study aims to compare the short-term clinical and echocardiographic outcomes of primary PCI in diabetic patients treated with insulin versus OADs.
Detailed Description
1. Diabetes mellitus (DM) is a major risk factor for cardiovascular disease (CVD), significantly increasing the risk of myocardial infarction (MI), heart failure, and mortality. Among patients with ST...
Eligibility Criteria
Inclusion
- Patients with DM (type 2) undergoing primary PCI for STEMI.1-
- Treated with either insulin or OADs prior to admission.2-
- 3- Age ≥18 year
Exclusion
- Type 1 DM.1- Patients on both insulin and OADs.2- 3-Prior coronary artery bypass graft (CABG) surgery. 4-Severe renal impairment (eGFR \<30 mL/min/1.73m²). 5-Hemodynamically unstable patients 6-moderate to severe VHD 7-Patients who were shifted from OADs to insulin during Follow-up
Key Trial Info
Start Date :
May 20 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 25 2026
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT06992466
Start Date
May 20 2025
End Date
February 25 2026
Last Update
May 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assuit
Asyut, Egypt